The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Mri Angiography Is Superior to Helical Ct for Detection of Hcc Prior to Liver Transplantation: An Explant Correlation
Open accessAbstract
Helical computerized tomography (CT) and magnetic resonance imaging (MRI) are used for staging of hepatocellular carcinoma (HCC) prior to curative treatments but underestimate tumor extension in 30% to 50% of cases when compared with pathologic explants. This study compares a new technology, MRI angiography (MRA), with triphasic helical CT in detection of HCC. Fifty cirrhotic patients, 29 with HCC, undergoing liver transplantation were analyzed. MRA was performed with a 3–D breath–hold fast spoiled gradient–echo sequence by using an effective section thickness of 2 to 2.5 mm. The gold standard was the pathologic examination (liver cut into 5–mm slices). One hundred twenty–seven lesions were identified at the explant: 76 HCC, 13 high–grade dysplastic nodules, 31 macroregenerative nodules, 7 hemangiomas. Diameter of the main HCC nodules was 29 ± 14 mm and 11 ± 7 mm for the 47 additional nodules. On a per nodule basis, sensitivity of MRA was superior to CT (58/76 [76%] vs. 43/70 [61%], respectively, P = .001). Sensitivity of MRA for detection of additional nodules decreased with size (>20 mm: 6/6 [100%]; 10-20 mm: 16/19 [84%]; <10 mm: 7/22 [32%]) and was superior to CT for nodules 10 to 20 mm (84% vs. 47%, P = .016). Nonspecific hypervascular nodules >5 mm at MRA were HCC in two thirds of the cases. In conclusion, MRA has a high diagnostic accuracy for HCC ≥ 10 mm and is more sensitive than triphasic helical CT in nodules sized 10 to 20 mm. MRA is the optimal technique for HCC staging prior to curative therapies. (Hepatology 2003;38:1034-1042).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mazzaferro, V., Regalia, E., Doci, R., Andreola, S., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M., Morabito, A., & Gennari, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341104 · Cited by 7,186
Llovet, J. M., Kelley, R. K., Villanueva, A., Singal, A. G., Pikarsky, E., Roayaie, S., Lencioni, R., Koike, K., Zucman-Rossi, J., & Finn, R. S. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00240-3 · Cited by 7,055
Self-citationClinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
Bruix, J., Sherman, M., Llovet, J. M., Beaugrand, M., Lencioni, R., Burroughs, A. K., Christensen, E., Pagliaro, L., Colombo, M., & Rodés, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00130-1 · Cited by 4,089
Self-citationPrognosis of Hepatocellular Carcinoma: The BCLC Staging Classification
Llovet, J., Brú, C., & Bruix, J. (1999) · Seminars in Liver Disease · doi:10.1055/s-2007-1007122 · Cited by 3,805
Self-citationEstimating the world cancer burden: Globocan 2000
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2001) · International Journal of Cancer · doi:10.1002/ijc.1440 · Cited by 3,721
Llovet, J. M., Fuster, J., & Bruix, J. (1999) · Hepatology · doi:10.1002/hep.510300629 · Cited by 1,708
Self-citationTerminology of nodular hepatocellular lesions
Wanless, I. R. (1995) · Hepatology · doi:10.1002/hep.1840220341 · Cited by 1,130
Prognostic prediction and treatment strategy in hepatocellular carcinoma
Bruix, J., & Llovet, J. M. (2002) · Hepatology · doi:10.1053/jhep.2002.32089 · Cited by 1,099
Self-citationGadolinium-enhanced MR aortography.
Prince, M. R. (1994) · Radiology · doi:10.1148/radiology.191.1.8134563 · Cited by 884
Llovet, J. M., Vilana, R., Brú, C., Bianchi, L., Salmeron, J. M., Boix, L., Ganau, S., Sala, M., Pagès, M., Ayuso, C., et al. (2001) · Hepatology · doi:10.1053/jhep.2001.24233 · Cited by 759
Self-citationgadolinium-enchanced MR aortography.
Kumar, P. (1994) · Radiology · Cited by 495
Llovet, J. M., Bruix, J., Fuster, J., Castells, A., Garcia-Valdecasas, J. C., Grande, L., França, A., Brú, C., Navasa, M., Ayuso, M. D., et al. (1998) · Hepatology · doi:10.1002/hep.510270616 · Cited by 382
Self-citationKrinsky, G. A., Lee, V. S., Theise, N. D., Weinreb, J. C., Rofsky, N. M., Diflo, T., & Teperman, L. W. (2001) · Radiology · doi:10.1148/radiology.219.2.r01ma40445 · Cited by 332
Rode, A., Bancel, B., Douek, P., Chevallier, M., Vilgrain, V., Picaud, G., Henry, L., Berger, F., Bizollon, T., Gaudin, J.-L., et al. (2001) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-200105000-00001 · Cited by 292
Imai, Y., Murakami, T., Yoshida, S., Nishikawa, M., Ohsawa, M., Tokunaga, K., Murata, M., Shibata, K., Zushi, S., Kurokawa, M., et al. (2000) · Hepatology · doi:10.1053/jhep.2000.9113 · Cited by 223
Reimer, P., Jähnke, N., Fiebich, M., Schima, W., Deckers, F., Marx, C., Holzknecht, N., & Saini, S. (2000) · Radiology · doi:10.1148/radiology.217.1.r00oc31152 · Cited by 188
Lim, J. H., Kim, C. K., Lee, W. J., Park, C. K., Koh, K. C., Paik, S. W., & Joh, J. W. (2000) · American Journal of Roentgenology · doi:10.2214/ajr.175.3.1750693 · Cited by 170
MR angiography: noninvasive vascular imaging of the abdomen
Laissy, J., Trillaud, H., & Douek, P. (2002) · Abdominal Imaging · doi:10.1007/s00261-001-0063-2 · Cited by 110
Kim, S. K., Kim, S. H., Lee, W. J., Kim, H. H., Seo, J. W., Choi, D., Lim, H. K., Lee, S. J., & Lim, J. H. (2002) · American Journal of Roentgenology · doi:10.2214/ajr.179.3.1790741 · Cited by 38
Mori, K., Scheidler, J. E., Helmberger, T. K., Holzknecht, N., Schauer, R. J., Schirren, C. A., Bittmann, I., Dugas, M., & Reiser, M. F. (2002) · American Journal of Roentgenology · doi:10.2214/ajr.179.4.1791045 · Cited by 37
Cited by
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Self-citationManagement of Hepatocellular Carcinoma *
Bruix, J., & Sherman, M. (2005) · Hepatology · doi:10.1002/hep.20933 · Cited by 5,857
Self-citationEASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
“However, underestimation of 25–30% is expected even with the best state-of-the-art technology [126,127].”
BackgroundModified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
Lencioni, R., & Llovet, J. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1247132 · Cited by 4,329
Self-citationLlovet, J. M., Burroughs, A., & Bruix, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14964-1 · Cited by 3,608
Self-citation
Metadata
- Authors
- Burrel, M., Llovet, J. M., Ayuso, C., Iglesias, C., Sala, M., Miquel, R., Caralt, T., Ayuso, J. R., Solé, M., Sanchez, M., Brú, C., & Bruix, J.
- Venue
- Hepatology
- Published
- 2003-10
- Volume
- 38
- Issue
- 4
- Pages
- 1034-1042
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2106307128
- Cited by
- 451
- References
- 20
- FWCI
- 12.85
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.